An International Publisher for Academic and Scientific Journals
Author Login 
Scholars Journal of Applied Medical Sciences | Volume-10 | Issue-03
“Comparative Evaluation of Caudal Tramadol and Adjuvant to Bupivacaine in Paediatric Age Group”
Md. Mahbub Ur Rahman, Md. Shafiqul Islam, SM Masum Billah
Published: March 30, 2022 | 139 87
DOI: 10.36347/sjams.2022.v10i03.019
Pages: 385-388
Downloads
Abstract
Background: Caudal anaesthesia is a type of regional anaesthesia in which local anesthetic is injected into epidural space. It is most popular regional anaesthesia with a predictable level of blockade used in paediatric surgeries. Adjuvants can be added to local anaesthetics for prolonging the duration of analgesia. Objective: To find out the duration of analgesia of caudal Bupivacaine in combination with Tramadol. Methods: This prospective, randomised, double-blind, comparative study was done in Department of Anesthesiology, Sher-e-bangla Medical College Hospital, Barishal, Bangladesh from June to December 2020. Total of 50 patients, aged between 2 to 9 years undergoing elective lower abdominal, urological and lower extremity surgeries. The patients were randomized to group A (n=25) receiving 1 ml/kg of 0.25% bupivacaine and group B (n=25) receiving 1 ml/kg of 0.25% bupivacaine plus 1mg/kg of tramadol caudally. Duration of analgesia, hemodynamic responses and adverse effects were noted and analysed. Results: Thirty patients in both groups were comparable with regard to demographic data and hemodynamic response and were statistically non-significant (P>0.05). It was observed that the mean duration of analgesia was significantly longer in group B (468.5±164.5 min versus 241.5±69.4 min, P<0.001). One patient in each group had postoperative vomiting. Conclusion: This study concludes that Tramadol 1 mg/kg can be added to 0.25% Bupivacaine for caudal analgesia with total volume of 1 ml/kg to prolong the duration of postoperative analgesia in children undergoing lower abdominal, urological, lower extremity surgery without an increase of adverse effects.